Source:http://linkedlifedata.com/resource/pubmed/id/18071306
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
23
|
pubmed:dateCreated |
2008-5-22
|
pubmed:abstractText |
Adult T-cell leukemia (ATL) is a mature CD4+ T-cell malignancy etiologically associated with human T-cell leukemia virus type 1 (HTLV-1). Primary ATL cells frequently express CCR4 at high levels. Since HTLV-1 Tax does not induce CCR4 expression, transcription factor(s) constitutively active in ATL may be responsible for its strong expression. We identified an activator protein-1 (AP-1) site in the CCR4 promoter as the major positive regulatory element in ATL cells. Among the AP-1 family members, Fra-2, JunB and JunD are highly expressed in fresh primary ATL cells. Consistently, the Fra-2/JunB and Fra-2/JunD heterodimers strongly activated the CCR4 promoter in Jurkat cells. Furthermore, Fra-2 small interfering RNA (siRNA) or JunD siRNA, but not JunB siRNA, effectively reduced CCR4 expression and cell growth in ATL cells. Conversely, Fra-2 or JunD overexpression promoted cell growth in Jurkat cells. We identified 49 genes, including c-Myb, BCL-6 and MDM2, which were downregulated by Fra-2 siRNA in ATL cells. c-Myb, BCL-6 and MDM2 were also downregulated by JunD siRNA. As Fra-2, these proto-oncogenes were highly expressed in primary ATL cells but not in normal CD4+ T cells. Collectively, aberrantly expressed Fra-2 in association with JunD may play a major role in CCR4 expression and oncogenesis in ATL.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/CCR4 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/FOSL2 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Fos-Related Antigen-2,
http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins c-jun,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Small Interfering,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, CCR4
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
1476-5594
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:day |
22
|
pubmed:volume |
27
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
3221-32
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:18071306-Binding Sites,
pubmed-meshheading:18071306-Cell Culture Techniques,
pubmed-meshheading:18071306-Cell Line, Tumor,
pubmed-meshheading:18071306-Cell Proliferation,
pubmed-meshheading:18071306-Fos-Related Antigen-2,
pubmed-meshheading:18071306-Gene Expression Profiling,
pubmed-meshheading:18071306-Gene Expression Regulation, Leukemic,
pubmed-meshheading:18071306-Humans,
pubmed-meshheading:18071306-Jurkat Cells,
pubmed-meshheading:18071306-Leukemia-Lymphoma, Adult T-Cell,
pubmed-meshheading:18071306-Oligonucleotide Array Sequence Analysis,
pubmed-meshheading:18071306-Promoter Regions, Genetic,
pubmed-meshheading:18071306-Protein Binding,
pubmed-meshheading:18071306-Proto-Oncogene Proteins c-jun,
pubmed-meshheading:18071306-RNA, Small Interfering,
pubmed-meshheading:18071306-Receptors, CCR4
|
pubmed:year |
2008
|
pubmed:articleTitle |
Aberrant expression of Fra-2 promotes CCR4 expression and cell proliferation in adult T-cell leukemia.
|
pubmed:affiliation |
Department of Microbiology, Kinki University School of Medicine, Osaka, Japan.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|